Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Bing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Endothelial Cells, Islets of Langerhans, CRISPR-Cas Systems, Microvessels. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
The integrity of the pancreatic islet microvasculature is critical for endocrine function, yet it is progressively compromised by glucotoxicity in diabetes. While matrix metalloproteinases are implicated, the role of stromelysin‐1 as a potential upstream driver of endothelial dysfunction remains poorly defined. The aim of our study was to elucidate the role of stromelysin‐1 in mediating glucotoxic injury to islet microvascular endothelial cells (IMECs). To this end, we employed a CRISPR/Cas9‐mediated knockout of stromelysin‐1 in IMECs. Cellular functions, including proliferation, migration, and angiogenesis, were assessed using IncuCyte ZOOM live‐cell imaging, while endothelial barrier integrity was quantified via a 40 kDa dextran flux assay. Additionally, the secretome was profiled using a cytokine antibody array. We found that genetic ablation of stromelysin‐1 conferred protection against glucotoxicity. Stromelysin‐1 KO IMECs exhibited significantly enhanced proliferation, migration, and angiogenic capacity compared to wild‐type controls. Furthermore, stromelysin‐1 deficiency restored endothelial monolayer integrity by attenuating high‐glucose‐induced hyperpermeability. These functional improvements were linked to a remodelling of the secretome, characterised by decreased secretion of the pro‐degradative MMP‐2 and increased secretion of the anti‐inflammatory cytokine IL‐10 and the endogenous inhibitor TIMP‐2. Overall, our findings establish stromelysin‐1 as a crucial mediator of glucotoxic injury in islet microvascular endothelial cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- International Center of Microvascular Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Diabetes Research Center, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Science, Beijing, China.
- Laboratory of Electron Microscopy, Ultrastructural Pathology Center, Peking University First Hospital, Beijing, China.
ORCID-Profile: Bing Wang, Weiqi Liu, Yuan Li, Qin Ouyang, Yingyu Wang, Xiang Xu, Bingwei Li, Ruijuan Xiu, Xu Zhang, Mingming Liu
Förderung
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, B., Liu, W., Li, Y., Ouyang, Q., Wang, Y., Xu, X., Li, B., Xiu, R., Zhang, X., & Liu, M. (2026). Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71098
Vancouver
Wang B, Liu W, Li Y, Ouyang Q, Wang Y, Xu X, et al. Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71098
BibTeX
@article{Wang2026,
author = {Wang, Bing and Liu, Weiqi and Li, Yuan and Ouyang, Qin and Wang, Yingyu and Xu, Xiang and Li, Bingwei and Xiu, Ruijuan and Zhang, Xu and Liu, Mingming},
title = {Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71098}
}
EUVIMED